Noom Competitor Ourpath Rebrands As Second Nature, Raises $10m Series A

Back in 2018, OurPath emerged as a startup in the U.K. tackling the problem of diabetes. The company helped customers fight the disease, and raised a $3 million round of funding by combining advice from health experts with tracking technology via a smartphone app to help people build healthy habits and lose weight. Now rebranded as Second Nature, it has raised a fresh $10 million in Series A funding. New investors include Uniqa Ventures, the venture capital fund of Uniqa, a European insurance group, and the founders of mySugr, the digital diabetes management platform, which was acquired by health giant Roche . The round also secured the backing of existing investors including Connect and Speedinvest, two European seed funds, and Bethnal Green Ventures, the early-stage Impact investor, as well as angels including Taavet Hinrikus, founder of TransferWise. This new injection takes the total investment in the company to $13 million. Competitors to the company include Weight Watchers and Noom, which provides a similar program and has raised $114.7 million. Second Nature claims to have a different, more intensive and personalized approach to create habit change.